TORONTO, Feb. 4, 2026 /PRNewswire/ -- The future of drug development starts with smarter early-phase trials. Moving from first-in-human (FIH) to proof-of-concept (POC) is a major milestone, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results